Dendritic Cell/Tumor Fusion Vaccine
03-221
Phase 2 mab terminated
Quick answer
Dendritic Cell/Tumor Fusion Vaccine for Breast Cancer is a Phase 2 program (mab) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- UNITED THERAPEUTICS Corp
- Indication
- Breast Cancer
- Phase
- Phase 2
- Modality
- mab
- Status
- terminated